Deals Shaping the Medical Industry, September 2016

 
• By Beth Allan, Steven Muntner, Maureen Riordan, and Deanna Kamienski

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2016.

Bio-Techne Corp. paid $250mm cash to acquire privately held molecular pathology firm Advanced Cell Diagnostics Inc. (ACD). The deal could also include up to $75mm in earn-outs. (Aug.)

The deal marks Bio-Techne's foray into the genomics field. ACD develops and sells genomic analysis consumables for its RNA in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deal-Making

More from In Vivo